The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
Open accessAbstract
Hypoxia is a pervasive microenvironmental factor that affects normal development as well as tumor progression. In most normal cells, hypoxia stabilizes hypoxia-inducible transcription factors (HIFs), particularly HIF-1, which activates genes involved in anaerobic metabolism and angiogenesis. As hypoxia signals a cellular deprivation state, HIF-1 has also been reported to counter the activity of MYC, which encodes a transcription factor that drives cell growth and proliferation. Since many human cancers express dysregulated MYC, we sought to determine whether HIF-1 would in fact collaborate with dysregulated MYC rather countering its function. Here, using the P493-6 Burkitt's lymphoma model with an inducible MYC, we demonstrate that HIF-1 cooperates with dysregulated c-Myc to promote glycolysis by induction of hexokinase 2, which catalyzes the first step of glycolysis, and pyruvate dehydrogenase kinase 1, which inactivates pyruvate dehydrogenase and diminishes mitochondrial respiration. We also found the collaborative induction of vascular endothelial growth factor (VEGF) by HIF-1 and dysregulated c-Myc. This study reports the previously unsuspected collaboration between HIF-1 and dysregulated MYC and thereby provides additional insights into the regulation of VEGF and the Warburg effect, which describes the propensity for cancer cells to convert glucose to lactate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To preferentially engage aerobic glycolysis, cancer cells frequently co-opt several pathways, including the HIF/hypoxia transcriptional program, to enhance PDK1 expression and achieve PDHC repression (142).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Self-citationJaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“Oxygen regulation of HIF-1 levels depends on the HIF-1 oxygen-dependent domain, which contains two prolyl residues (402 and 564), which are hydroxylated by prolyl hydroxylase in the presence of oxygen (4, 33 , 34, 52, 70, 73).”
BackgroundActivation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Self-citationKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Self-citationOn Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Flagged first, then by citations
Research works printed but not linked: 2
- Mateyak M. K., 1997, Cell Growth Differ., 8, 1039
- Mazure N. M., 2002, Cancer Res., 62, 1158
Cited by
Sorted by citations
Items 201–300 of 660
Davis, L., Recktenwald, M., Hutt, E., Fuller, S., Briggs, M., Goel, A., & Daringer, N. (2022) · Cancers · doi:10.3390/cancers14051259 · Cited by 83
Wang, R., Wang, M., Ye, J., Sun, G., & Sun, X. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4798 · Cited by 83
Targeting mitochondria as a therapeutic target in cancer
Wenner, C. E. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22788 · Cited by 82
B-Cell Metabolic Remodeling and Cancer
Franchina, D. G., Grusdat, M., & Brenner, D. (2018) · Trends in cancer · doi:10.1016/j.trecan.2017.12.006 · Cited by 85
The Progress and Development of GLUT1 Inhibitors Targeting Cancer Energy Metabolism
Meng, Y., Xu, X. J., Luan, H., Li, L., Dai, W., Li, Z., & Bian, J. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0052 · Cited by 85
Metabolic traits of cancer stem cells
Peixoto, J., & Lima, J. P. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033464 · Cited by 81
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0947-4 · Cited by 80
Dafni, H., Larson, P. E. Z., Hu, S., Yoshihara, H. A. I., Ward, C. S., Venkatesh, H. S., Wang, C., Zhang, X., Vigneron, D. B., & Ronen, S. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0883 · Cited by 77
Zuo, S., Wu, L., Wang, Y., & Yuan, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00274 · Cited by 76
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures
Graham, N. A., Minasyan, A., Lomova, A., Cass, A. A., Balanis, N. G., Friedman, M., Chan, S. T., Zhao, S. R., Delgado, A., Go, J. L., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167159 · Cited by 78
Lecarpentier, Y., CLAES, V. A., Vallée, A., & Hébert, J. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0144-7 · Cited by 76
Antitumor Drugs and Their Targets
Dembić, Z. (2020) · Molecules · doi:10.3390/molecules25235776 · Cited by 75
cGMP-Dependent Protein Kinases as Potential Targets for Colon Cancer Prevention and Treatment
Browning, D. D., Kwon, I., & Wang, R. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.142 · Cited by 73
Li, C., Kim, S., Rai, D., Bolla, A. R., Adhvaryu, S. G., Kinney, M. C., Robetorye, R. S., & Aguiar, R. C. T. (2009) · Blood · doi:10.1182/blood-2009-01-202028 · Cited by 73
Ashrafian, H., O′Flaherty, L., Adam, J., Steeples, V., Chung, Y., East, P., Vanharanta, S., Lehtonen, H. J., Nye, E. L., Hatipoglu, E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1949 · Cited by 72
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Kant, R., Manne, R., Anas, M., Penugurti, V., Chen, T., Pan, B., Hsu, C.-C., & Lin, H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.001 · Cited by 76
The impact of MYC expression in lymphoma biology: Beyond Burkitt lymphoma
Smith, S. M., Anastasi, J., Cohen, K. S., & Godley, L. A. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.08.002 · Cited by 75
Investigational cancer drugs targeting cell metabolism in clinical development
Sborov, D. W., Haverkos, B. M., & Harris, P. J. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.960077 · Cited by 72
Schwartz, S. (2010) · Oncology Reports · doi:10.3892/or_00000778 · Cited by 71
Myc-mediated SDHA acetylation triggers epigenetic regulation of gene expression and tumorigenesis
Li, S., Huang, D., Shen, S., Cai, Y., Xing, S., Wu, G., Jiang, Z., Hao, Y., Yuan, M., Wang, N., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0179-8 · Cited by 72
Self-citationMlakar, V., Morel, E., Mlakar, S. J., Ansari, M., & Gumy‐Pause, F. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01967-x · Cited by 72
Jha, M. K., Jeon, S., & Suk, K. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143586 · Cited by 71
Classical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2
Londhe, P., Yu, P. Y., Ijiri, Y., Ladner, K. J., Fenger, J. M., London, C. A., Houghton, P. J., & Guttridge, D. C. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00104 · Cited by 71
Advances in the interaction of glycolytic reprogramming with lactylation
Li, Y., Cao, Q., Hu, Y., He, B., Cao, T., Tang, Y., Zhou, X. P., Lan, X. P., & Liu, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116982 · Cited by 71
Koh, M. Y., Spivak-Kroizman, T. R., & Powis, G. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-78281-0_3 · Cited by 70
Metabolic Reprogramming in Thyroid Carcinoma
Coelho, R. G., Fortunato, R. S., & de Carvalho, D. P. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00082 · Cited by 67
Regulation of pyruvate metabolism in metabolic-related diseases
Jeoung, N. H., Harris, C. R., & Harris, R. A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9284-2 · Cited by 68
c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α
Chen, C. Y., Cai, S., Wang, G., Cao, X., Yang, X., Luo, X., Feng, Y., & Hu, J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.006 · Cited by 67
Obesity and Cancer Metabolism: A Perspective on Interacting Tumor–Intrinsic and Extrinsic Factors
Doerstling, S. S., O’Flanagan, C. H., & Hursting, S. D. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00216 · Cited by 68
Keoh, L. Q., Chiu, C.-F., & Ramasamy, T. S. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10956-y · Cited by 66
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00352 · Cited by 68
Zhang, M., Liu, T., Sun, H., Weng, W., Zhang, Q., Liu, C., Yang, H., & Sheng, W. (2018) · Cancer Science · doi:10.1111/cas.13562 · Cited by 67
Autophagy: a targetable linchpin of cancer cell metabolism
Leone, R. D., & Amaravadi, R. K. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.01.008 · Cited by 68
Carbon Source Metabolism and Its Regulation in Cancer Cells
Yin, C., Qie, S., & Sang, N. (2012) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v22.i1.20 · Cited by 67
B cell immunometabolism in health and disease
Martinis, E., Tonon, S., Colamatteo, A., Cava, A. L., Matarese, G., & Pucillo, C. E. M. (2025) · Nature Immunology · doi:10.1038/s41590-025-02102-0 · Cited by 65
Jha, M. K., Jeon, S., & Suk, K. (2012) · Current Neuropharmacology · doi:10.2174/157015912804499528 · Cited by 64
Zhou, L. Q., Li, M., Yu, X., Gao, F., & Li, W. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.31749 · Cited by 63
Metabolic Rewiring in Glioblastoma Cancer: EGFR, IDH and Beyond
Khayari, A. E., Bouchmaa, N., Taïb, B., Wei, Z., Zeng, A., & Fatimy, R. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.901951 · Cited by 65
Tumor metabolism regulating chemosensitivity in ovarian cancer
Han, C. Y., Patten, D. A., Richardson, R. B., Harper, M., & Tsang, B. K. (2018) · Genes & Cancer · doi:10.18632/genesandcancer.176 · Cited by 62
Hypoxia, Inflammation and Necrosis as Determinants of Glioblastoma Cancer Stem Cells Progression
Papale, M., Buccarelli, M., Mollinari, C., Russo, M. A., Pallini, R., Ricci‐Vitiani, L., & Tafani, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082660 · Cited by 66
Essaghir, A., & Demoulin, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039666 · Cited by 61
Talwar, S., Jin, J., Carroll, B. L., Liu, A., Gillespie, M. B., & Palanisamy, V. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.255927 · Cited by 63
Glucose metabolic phenotype of pancreatic cancer
Chan, A. K. C., Bruce, J. I. E., & Siriwardena, A. K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i12.3471 · Cited by 62
Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122537 · Cited by 61
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0219-5 · Cited by 62
Afonso, J., Pinto, T., Simoes‐Sousa, S., Schmitt, F. C., Longatto‐Filho, A., Pinheiro, C. M., Marques, H., & Baltazar, F. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00426-2 · Cited by 60
Development of targeted angiogenic medicine
Loges, S., Roncal, C., & Carmeliet, P. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03203.x · Cited by 62
The Metabolic Heterogeneity and Flexibility of Cancer Stem Cells
Tanabe, A., & Sahara, H. (2020) · Cancers · doi:10.3390/cancers12102780 · Cited by 61
Huang, Y., Zhen, Y., Chen, Y., Sui, S., & Zhang, L. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115842 · Cited by 59
The Caenorhabditis elegans Myc-Mondo/Mad Complexes Integrate Diverse Longevity Signals
Johnson, D. W., Llop, J. R., Farrell, S. F., Yuan, J., Stolzenburg, L. R., & Samuelson, A. V. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004278 · Cited by 60
Zhang, S., Hu, X., Zhang, W., & Tam, K. Y. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01828 · Cited by 59
PGC-1β promotes enterocyte lifespan and tumorigenesis in the intestine
Bellafante, E., Morgano, A., Salvatore, L., Murzilli, S., Tullio, G. D., D’Orazio, A., Latorre, D., Villani, G., & Moschetta, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415279111 · Cited by 60
Yustein, J. T., Liu, Y.-C., Gao, P., Jie, C., Le, A., Vuica‐Ross, M., Chng, W. J., Eberhart, C. G., Bergsagel, P. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901230107 · Cited by 58
Self-citationAerobic glycolysis in amyotrophic lateral sclerosis and Huntington’s disease
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0075 · Cited by 59
Ahmad, A. M., Ahmad, S., Malcolm, K. C., Miller, S. M., Hendry‐Hofer, T. B., Schaack, J. B., & White, C. W. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0107oc · Cited by 57
Low Oxygen Tension Enhances Hepatitis C Virus Replication
Vassilaki, N., Kalliampakou, K. I., Kotta‐Loizou, I., Befani, C. D., Liakos, P., Simos, G., Mentis, A. F., Kalliaropoulos, A., Doumba, P. P., Smirlis, D., et al. (2012) · Journal of Virology · doi:10.1128/jvi.02534-12 · Cited by 59
Kim, S.-H., Kim, S., & Ku, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17798 · Cited by 57
Fang, E., Wang, X., Wang, J., Hu, A., Song, H., Yang, F., Li, D., Xiao, W., Chen, Y., Guo, Y., et al. (2020) · Theranostics · doi:10.7150/thno.37383 · Cited by 56
Self-citationCampbell, I. H., & Campbell, H. J. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110299 · Cited by 56
Wei, X. S., Hou, Y., Long, M., Jiang, L., & Du, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.927329 · Cited by 58
Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma
Borsi, E., Perrone, G., Terragna, C., Martello, M., Dico, A. F., Solaini, G., Baracca, A., Sgarbi, G., Pasquinelli, G., Valente, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1736 · Cited by 57
Tyr-94 Phosphorylation Inhibits Pyruvate Dehydrogenase Phosphatase 1 and Promotes Tumor Growth
Shan, C., Kang, H., Elf, S., Xie, J., Gu, T.-L., Aguiar, M., Lonning, S. M., Hitosugi, T., Chung, T., Arellano, M. L., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.581124 · Cited by 56
Targeting the Warburg effect in hematological malignancies: from PET to therapy
Shanmugam, M., McBrayer, S. K., & Rosen, S. T. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32832f57ec · Cited by 58
MicroRNAs in pancreatic cancer metabolism
Singh, P. K., Brand, R. E., & Mehla, K. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.63 · Cited by 59
In vivo Reprogramming of Cancer Metabolism by MYC
Camarda, R., Williams, J. R., & Goga, A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00035 · Cited by 56
Influence of low oxygen tensions on expression of pluripotency genes in stem cells
Szabłowska‐Gadomska, I., Zayat, V., & Bużańska, L. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1825 · Cited by 56
Yoshino, S., Hara, T., Nakaoka, H. J., Kanamori, A., Murakami, Y., Seiki, M., & Sakamoto, T. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.19 · Cited by 57
Shin, N., Lee, H., Sim, D. Y., Im, E., Park, J. E., Park, W. Y., Cho, A. R., Shim, B. S., & Kim, S. (2021) · Phytotherapy Research · doi:10.1002/ptr.7087 · Cited by 54
The Role of Reprogrammed Glucose Metabolism in Cancer
Ediriweera, M. K., & Jayasena, S. (2023) · Metabolites · doi:10.3390/metabo13030345 · Cited by 55
Boufaied, N., Chetta, P., Hallal, T., Cacciatore, S., Lalli, D., Luthold, C., Homsy, K., Imada, E. L., Syamala, S., Photopoulos, C., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-0519 · Cited by 59
Self-citationThe mitochondrial bioenergetic capacity of carcinomas
Formentini, L., Martínez‐Reyes, I., & Cuezva, J. M. (2010) · IUBMB Life · doi:10.1002/iub.352 · Cited by 55
MAZZIO, E. A., Smith, B., & Soliman, K. F. A. (2009) · Cell Biology and Toxicology · doi:10.1007/s10565-009-9138-6 · Cited by 54
Wrzesinski, K., & Fey, S. J. (2018) · Bioengineering · doi:10.3390/bioengineering5010022 · Cited by 55
Xu, L., Cao, Y., Ya, X., Li, R., & Xu, X. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300238 · Cited by 54
P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy
Zhang, D., Zheng, J., & Pei, D. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-115 · Cited by 55
Jin, Y., Cai, Q., Shenoy, A. K., Lim, S., Zhang, Y., Charles, S., Tarrash, M., Fu, X., Kamarajugadda, S., Trevino, J. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7159 · Cited by 55
Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies
de Wit, S., Glen, C., de Boer, R. A., & Lang, N. N. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac132 · Cited by 54
Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence
Gitenay, D., Wiel, C., Lallet-Daher, H., Vindrieux, D., Aubert, S., Payen, L. F., Simonnet, H., & Bernard, D. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.63 · Cited by 54
Richards, J. G., Sardella, B. A., & Schulte, P. M. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00192.2008 · Cited by 52
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8486-x · Cited by 54
Mitochondrial Metabolism Inhibitors for Cancer Therapy
Ramsay, E. E., Hogg, P. J., & Dilda, P. J. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0584-5 · Cited by 52
Peng, Y., Liu, J., Wang, Z., Cui, C., Zhang, S., Zhang, S., Gao, P., Hou, Z., Liu, H., Guo, J., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00960-x · Cited by 50
Self-citationYoo, Y., Christensen, J., & Huang, E. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2360 · Cited by 50
Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?
Alves, Â., Mamede, A. C., Alves, M. G., Oliveira, P. F., Rocha, S. M., Botelho, M. F., & Maia, C. J. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009618666180430144441 · Cited by 50
Wang, J., Ma, X., Jones, H. M., Chan, L. L., Song, F., Zhang, W., Bae-Jump, V. L., & Zhou, C. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0226-x · Cited by 50
MEK1/2 Inhibition Decreases Lactate in BRAF-Driven Human Cancer Cells
Miniotis, M. F., Arunan, V., Eykyn, T. R., Marais, R., Workman, P., Leach, M. O., & Beloueche‐Babari, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1969 · Cited by 49
Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy
Kumar, R., Mishra, A., Gautam, P., Feroz, Z., Vijayaraghavalu, S., Likos, E., Shukla, G. C., & Kumar, M. (2022) · Cancers · doi:10.3390/cancers14215268 · Cited by 50
Vasculogenic Mimicry of HT1080 Tumour Cells In Vivo: Critical Role of HIF-1α-Neuropilin-1 Axis
Misra, R. M., Bajaj, M. S., & Kale, V. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050153 · Cited by 48
Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation
Abooshahab, R., Gholami, M., Sanoie, M., Azizi, F., & Hedayati, M. (2019) · Endocrine · doi:10.1007/s12020-019-01904-1 · Cited by 48
Yu, M., Pan, Q., Li, W., Du, T., Huang, F., Wu, H., He, Y., Wu, X., & Shi, H. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155045 · Cited by 47
Saga, I., Shibao, S., Okubo, J., Osuka, S., Kobayashi, Y., YAMADA, S., Fujita, S., Urakami, K., Kusuhara, M., Yoshida, K., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou096 · Cited by 47
Pyruvate dehydrogenase kinase regulates hepatitis C virus replication
Jung, G., Jeon, J., Choi, Y., Jang, S. Y., Park, S. Y., Kim, S.-W., Byun, J., Kim, M. K., Lee, S., Shin, E., et al. (2016) · Scientific Reports · doi:10.1038/srep30846 · Cited by 47
Cai, C., Ye, G.-D., Shen, D., Zhang, W., Chen, M.-L., Chen, X., Han, D., Mi, Y., Luo, Q., Cai, W., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0769-4 · Cited by 47
Mitochondrial Alterations During Carcinogenesis
Wang, X., Peralta, S., & Moraes, C. T. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00004-6 · Cited by 47
Meng, T., Zhang, D., Xie, Z., Yu, T., Wu, S., Wyder, L., Regenass, U., Hilpert, K., Huang, M., Geng, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5010144 · Cited by 46
Increase in mitochondrial biogenesis, oxidative stress, and glycolysis in murine lymphomas
Samper, E., Morgado-Palacin, L., Estrada, J. C., Bernad, A., Hubbard, A., Cadenas, S., & Melov, S. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.036 · Cited by 46
Wu, M., Zhang, M., Ma, Y., Liu, F., Chen, S., Lu, J., & Chen, H. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.06.010 · Cited by 46
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
Chan, K. I., Zhang, S., Li, G., Xu, Y., Cui, L., Wang, Y., Su, H., Tan, W., & Zhong, Z. (2024) · Aging and Disease · doi:10.14336/ad.2023.0520 · Cited by 46
Das, L., & Vinayak, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099583 · Cited by 45
Elsayed, G. H., Dacrory, S., & Fahim, A. M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.083 · Cited by 45
Metadata
- Authors
- Kim, J.-W., Gao, P., Liu, Y.-C., Semenza, G. L., & Dang, C. V.
- Affiliations
- Division of Hematology, Department of Medicine
- Graduate Program of Pathobiology
- Johns Hopkins University (US)
- Corresponding author
- Dang, Chi V.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2007-11-01
- Volume
- 27
- Issue
- 21
- Pages
- 7381-7393
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2169056
- OpenAlex
- W2105250121
- Cited by
- 658
- References
- 87
- Citations by year
- 2026: 21 · 2025: 29 · 2024: 28 · 2023: 31 · 2022: 49 · 2021: 60 · 2020: 45 · 2019: 48 · 2018: 38 · 2017: 36 · 2016: 38 · 2015: 28 · 2014: 44 · 2013: 29 · 2012: 35
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health (n01hv28180-13-0-0, NO1-HV-28180)
- National Heart, Lung, and Blood Institute (N01 HV028180, N02-HV-28180)
- National Cancer Institute (CA 57341, R01CA057341, CA52497)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- HIF-1, c-Myc, vascular endothelial growth factor, hexokinase 2, pyruvate dehydrogenase kinase 1, Warburg effect, glycolysis, mitochondrial respiration, Burkitt lymphoma, tumor hypoxia, angiogenesis, cancer metabolism
- MeSH terms
- Pyruvate Dehydrogenase Acetyl-Transferring Kinase, Cell Line, DNA, Enzyme Induction, Glucose, Glycolysis, Hexokinase, Humans, Neoplasms, Protein Binding, Regulatory Sequences, Nucleic Acid, Proto-Oncogene Proteins c-myc, Protein Serine-Threonine Kinases, Vascular Endothelial Growth Factor A, Chromatin Immunoprecipitation, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
